Aernoud T.L. Fiolet

Colchicine in Patients with Chronic Coronary Disease

Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text

Medicine, Cardiology, Pharmacology +15

C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease

P.M. Burger, Stefan Koudstaal, Arend Mosterd et al. · Journal of the American College of Cardiology · 2023 · 135 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics

Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom et al. · American Heart Journal · 2019 · 108 citations

Medicine, Cardiology, Pharmacology +9

Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy

Max J. M. Silvis, Aernoud T.L. Fiolet, Tjerk S.J. Opstal et al. · Atherosclerosis · 2021 · 63 citations · Full text

Veterinary Medicine, Cardiology, Immunology +17

Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

Aernoud T.L. Fiolet, Michiel H.F. Poorthuis, Tjerk S.J. Opstal et al. · EClinicalMedicine · 2024 · 58 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17